Clover Health Investments, Corp. (NASDAQ:CLOV) is one of the Best 52-Week Low Penny Stocks to Invest In. On February 26, Clover Health Investments, Corp. (NASDAQ:CLOV) released its fiscal Q4 2025 earnings. The company grew its revenue by 44.74% year-over-year to $487.7 million and topped expectations by $20.65 million. The EPS was negative $0.10 but remained in-line with the expectations.
Clover Health reported 38% year-over-year growth in Medicare advantage membership, ending the year with 113,803 members. Moreover, the full-year revenue reached $1.9 billion, reflecting 40% increase from fiscal 2024. Management noted 2025 to be a year of execution driven by strong member growth.
Looking ahead, the company expects 2026 to be the first profitable year on a GAAP net income basis, with net income ranging from breakeven to $20 million. Management expects to grow membership by 46% in 2026. Revenue for the year is projected between $2.81 billion and $2.92 billion, implying 49% year-over-year growth at the midpoint.
Jirsak/Shutterstock.com
Clover Health Investments, Corp. is a healthcare technology company focused on improving medical outcomes for seniors through Medicare Advantage plans and its proprietary software platform, Clover Assistant. It operates as a next-generation insurer providing PPO and HMO plans to Medicare beneficiaries.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
